share_log

基石藥業-B：截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

香港交易所 ·  Apr 5 04:30
Summary by Moomoo AI
基石藥業（02616.HK）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總額維持在2,000,000,000股，每股面值0.0001美元，法定/註冊股本總額為200,000美元。此外，公司的股份期權計劃中，首次公開發售前激勵計劃的股份期權數目經過行使和失效後減少了39,213股，而首次公開發售後僱員持股計劃的股份期權數目則增加了10,984,716股。本月內因行使期權所得資金總額為8,925.68港元。公司確認，所有證券發行均已獲董事會授權批准，並符合相關法律規定。
基石藥業（02616.HK）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總額維持在2,000,000,000股，每股面值0.0001美元，法定/註冊股本總額為200,000美元。此外，公司的股份期權計劃中，首次公開發售前激勵計劃的股份期權數目經過行使和失效後減少了39,213股，而首次公開發售後僱員持股計劃的股份期權數目則增加了10,984,716股。本月內因行使期權所得資金總額為8,925.68港元。公司確認，所有證券發行均已獲董事會授權批准，並符合相關法律規定。
KEYSTONE PHARMACEUTICALS (02616.HK) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 5, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED MARCH 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding balance of 2,000,000,000 shares, with a face value of $0.0001 per share and a total regulated/registered share capital of $200,000. In addition, the number of stock options in the Company's pre-IPO incentive plan decreased by 39,213 shares after exercise and expiration, and the number of stock options for the employee holding plan after the initial public offering increased by 10,984,716 shares. The total amount of capital gained from the exercise of options during the month was HK$8,925.68. The Company confirms that all securities issuances have been authorized by the Board of Directors and comply with the relevant legal requirements.
KEYSTONE PHARMACEUTICALS (02616.HK) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 5, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED MARCH 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding balance of 2,000,000,000 shares, with a face value of $0.0001 per share and a total regulated/registered share capital of $200,000. In addition, the number of stock options in the Company's pre-IPO incentive plan decreased by 39,213 shares after exercise and expiration, and the number of stock options for the employee holding plan after the initial public offering increased by 10,984,716 shares. The total amount of capital gained from the exercise of options during the month was HK$8,925.68. The Company confirms that all securities issuances have been authorized by the Board of Directors and comply with the relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more